← Back to Search

Intensive Exercise for Perinatal Stroke

N/A
Recruiting
Led By Jaynie Yang
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medical history and physical exam consistent with perinatal stroke
Hemiparesis in the upper and/or lower extremity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 9 months, 12 months
Awards & highlights

Study Summary

This trial will compare the effects of intense physical therapy to usual care in order to see if early intervention can improve gross motor function.

Who is the study for?
This trial is for children aged 8 months to 3 years who have had a perinatal stroke, leading to weakness in the arms and/or legs. Parents must commit to the training schedule and be able to communicate in English or French. Children with seizures affecting training, bilateral motor issues, recent leg treatments like Botox or surgery, or conditions causing regression can't join.Check my eligibility
What is being tested?
The study tests if early intensive exercise for young children's legs, guided by physical therapists and parents together, improves movement more than standard care does. It's a controlled test where some kids get this new method while others continue usual treatment routines.See study design
What are the potential side effects?
Since this trial involves physical exercise as an intervention rather than medication, side effects may include typical responses to increased activity such as muscle soreness or fatigue. However specific side effects will depend on each child's condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stroke around the time I was born.
Select...
I have weakness on one side of my body.
Select...
My child is between 8 months and 3 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 9 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gross Motor Function Measure (GMFM-66) - change from baseline
Secondary outcome measures
Ankle joint angle at full dorsiflexion - change from baseline
Ankle joint angle at onset of stretch reflex - change from baseline
Resource use questionnaire
+2 more
Other outcome measures
Qualitative study using Interpretative Description methodology

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate GroupExperimental Treatment1 Intervention
The intervention is intensive exercise, delivered over 12 weeks beginning on admission to the study. The group will then be followed for 9 months post intervention.
Group II: Delay GroupActive Control1 Intervention
The group will be followed for 6 months with no intervention. After 6 months the group will be given the opportunity to receive the same intensive exercise intervention as the Immediate group. The group will be followed for 3 months following the intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive exercise
2011
Completed Phase 4
~450

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,078 Total Patients Enrolled
2 Trials studying Perinatal Stroke
122 Patients Enrolled for Perinatal Stroke
Brain CanadaOTHER
18 Previous Clinical Trials
5,982 Total Patients Enrolled
Jaynie YangPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
25 Total Patients Enrolled

Media Library

Intensive exercise Clinical Trial Eligibility Overview. Trial Name: NCT03672864 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any openings for participation in this trial?

"Affirmative, clinicaltrials.gov specifies that this trial is currently recruiting patients; it was initially published on February 15th 2019 and has been recently updated on May 11th 2022. The investigators of the study require 56 participants to be recruited from 4 medical sites."

Answered by AI

Does this medical trial accept participants who are octogenarians?

"In keeping with the requirements for this experiment, only infants between 8 and 36 months of age are eligible to participate."

Answered by AI

How many individuals have been recruited for participation in this trial?

"Affirmative. Clinicaltrials.gov displays that this clinical trial began recruitment on February 15th 2019 and has recently been updated in respect to the 5th of May 2022. 56 individuals are sought from 4 locations for participation."

Answered by AI

What qualifications must one possess to be accepted into this experiment?

"This medical trial is seeking 56 participants with a history of stroke who are between 8 months and 3 years old. To be eligible, these children must exhibit signs of hemiparesis in their upper and/or lower body, have a physical exam that corresponds to perinatal strokes, as well as parental agreement to comply with the testing regime."

Answered by AI

What results are expected from this research endeavor?

"The primary outcome for this 3 to 12 month clinical trial will be a change in Gross Motor Function Measure (GMFM-66) from baseline. Secondary objectives involve assessing changes in Young Children's Participation and Environment Measure (YC-PEM), Portable Spasticity Assessment Device (PSAD)-measured stiffness at the ankle, and Pediatric Quality of Life Measure module for cerebral palsy’s five scales: daily activities, movement/balance, pain/hurt, fatigue, and eating activities."

Answered by AI
~7 spots leftby Feb 2025